Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05489237
Title A First-in-human (FIH) Study of IDRX-42 in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (GIST) [Study ID: StrateGIST 1]
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors IDRx, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | BEL

Facility Status City State Zip Country Details
University of Miami RECRUITING Miami Florida 33136 United States Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Oregon Health & Science University (OHSU) RECRUITING Portland Oregon 97239 United States Details
Temple University Health System (Temple Health) - Fox Chase Cancer Center (FCCC) - Main Campus RECRUITING Philadelphia Pennsylvania 19111-2497 United States Details
The University of Texas - MD Anderson Cancer Center RECRUITING Houston Texas 77030-4000 United States Details
Universitaire Ziekenhuizen (UZ) Leuven - Campus Gasthuisberg - Leuvens Kankerinstituut (Leuven Cancer Institute) (LKI) RECRUITING Leuven 3000 Belgium Details
HELIOS Kliniken GmbH - HELIOS Klinikum Berlin-Buch RECRUITING Berlin 13125 Germany Details
University Hospital Essen-West German Cancer Center RECRUITING Essen D - 45147 Germany Details
Vall d' Hebron Institute of Oncology (VHIO) RECRUITING Barcelona 08035 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field